Italia markets closed

ILMN Jan 2025 210.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,15000,0000 (0,00%)
Alla chiusura: 02:37PM EDT
Schermo intero
Chiusura precedente1,1500
Aperto1,1500
Denaro0,0000
Domanda4,3000
Prezzo d'esercizio210,00
Scadenza2025-01-17
Min-Max giorno1,1500 - 1,1500
Contratto - Min-MaxN/D
Volume16
Open Interest89
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera